(S (NP (DT This) (NN paper)) (VP (VBZ presents) (NP (NP (DT a) (NN method)) (PP (IN for) (NP (NP (NN 3D) (NN segmentation)) (PP (IN of) (NP (NP (NNS kidneys)) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ autosomal) (JJ dominant) (JJ polycystic) (NN kidney) (NN disease) (PRN (-LRB- -LRB-) (NP (NN ADPKD)) (-RRB- -RRB-))) (CC and) (NP (JJ severe) (JJ renal) (NML (NML (NN insufficiency) (PRN (, ,) (S (VP (VBG using) (NP (VBN computed) (NN tomography)))))) (-LRB- -LRB-) (NML (NN CT)) (-RRB- -RRB-)) (NNS data)))))))))))) (. .))
(S (NP (NN ADPKD)) (ADVP (RB severely)) (VP (VBZ alters) (NP (NP (DT the) (NN shape)) (PP (IN of) (NP (DT the) (NNS kidneys)))) (PP (IN due) (PP (IN to) (NP (NP (NN non-uniform) (NN formation)) (PP (IN of) (NP (NNS cysts))))))) (. .))
(S (PP (IN As) (NP (DT a) (NN consequence))) (, ,) (NP (NP (ADJP (RB fully) (JJ automatic)) (NN segmentation)) (PP (IN of) (NP (JJ such) (NNS kidneys)))) (VP (VBZ is) (ADJP (RB very) (JJ challenging))) (. .))
(S (NP (PRP We)) (VP (VBP present) (NP (DT a) (NN segmentation) (NN method)) (PP (IN with) (NP (NP (JJ minimal) (NN user) (NN interaction)) (PP (VBN based) (PP (IN on) (NP (DT a) (NML (JJ random) (NN forest)) (NN classifier))))))) (. .))
(S (NP (NP (CD One)) (PP (IN of) (NP (NP (DT the) (JJ major) (NNS novelties)) (PP (IN of) (NP (DT the) (VBN proposed) (NN approach)))))) (VP (VBZ is) (NP (NP (DT the) (NN usage)) (PP (IN of) (NP (NP (JJ geodesic) (NN distance) (NNS volumes)) (PP (IN as) (NP (NP (JJ additional) (NN source)) (PP (IN of) (NP (NN information))))))))) (. .))
(S (NP (DT These) (NNS volumes)) (VP (VBP contain) (NP (DT the) (NN intensity) (JJ weighted) (NN distance)) (PP (IN to) (NP (NP (DT a) (JJ manual) (NN outline)) (PP (IN of) (NP (NP (DT the) (JJ respective) (NN kidney)) (PP (IN in) (NP (NP (NP (RB only) (CD one) (NN slice)) (-LRB- -LRB-) (PP (IN for) (NP (DT each) (NN kidney))) (-RRB- -RRB-)) (PP (IN of) (NP (DT the) (NN CT) (NN volume)))))))))) (. .))
(S (NP (PRP We)) (VP (VBP evaluate) (NP (PRP$ our) (NN method)) (ADVP (RB qualitatively) (CC and) (RB quantitatively)) (PP (IN on) (NP (NP (CD 55) (NN CT) (NNS acquisitions)) (VP (VBG using) (NP (NN ground) (NN truth) (NNS annotations)) (PP (IN from) (NP (JJ clinical) (NNS experts))))))) (. .))
